Genetic thrombophilia factor testing revealed an MTHFR mutation in both patients with an additional heterozygous PAI-1 gene polymorphism in patient B, but no evidence of a factor V ARG506 mutation or prothrombin G20210A mutation could be found. This evidence concerns the gene F2 and Rare hereditary thrombophilia.